HealthBridge US Responds to HHS OIG Advisory Opinion Clearing the Way for Food-as-Medicine Produce Benefits at Federally Qualified Health Centers

The Office of Inspector General (OIG) at the U.S. Department of Health and Human Services (HHS) has issued a favorable advisory opinion regarding a federally qualified health center's (FQHC) proposal to give free produce to financially needy patients managing diabetes or hypertension. HealthBridge US, an organization focused on advancing accountable, evidence-based approaches to chronic-disease care, is issuing this statement to summarize the federal opinion in plain language for health centers, payers, food-is-medicine program designers, and policymakers evaluating similar nutrition-support initiatives.

HealthBridge US is sharing this update as an independent, plain-language summary of a federal regulatory development. HealthBridge US is not affiliated with, and does not speak on behalf of, HHS, OIG, the requesting health center, or any government agency. Readers seeking the original federal materials should consult the government sources listed at the end of this release. Nothing in this release constitutes legal advice; organizations considering similar programs should consult qualified fraud-and-abuse counsel.

What OIG Announced

OIG's newly published guidance, issued as Advisory Opinion 26-16, examines a proposed six-month food-as-medicine initiative developed by a federally qualified health center that primarily serves lower-income patients. The health center asked OIG to evaluate whether providing free produce to program participants would run afoul of two federal fraud-and-abuse authorities: the Anti-Kickback Statute (AKS) and the Beneficiary Inducements provision of the Civil Monetary Penalties Law (CMPL). Both authorities are designed, in different ways, to prevent providers from using free or discounted items to improperly steer patients toward services billed to federal health programs.

OIG concluded that the proposed arrangement did, in fact, implicate both statutes — meaning the free produce could be viewed as remuneration capable of influencing which provider a patient chooses for reimbursable care. Despite reaching that conclusion, OIG exercised its enforcement discretion and stated it would not pursue administrative sanctions against the health center based on the specific facts, safeguards, and clinical design of the program as proposed. Advisory opinions of this kind are legally binding only on the organization that requested them and apply strictly to the facts presented, but they are closely watched across the health-care field because they reveal how the federal government is currently thinking about emerging models of care.

The Proposed Food-as-Medicine Arrangement

According to OIG's published opinion, the requesting health center proposed to enroll approximately 50 financially needy patients diagnosed with diabetes or hypertension in a structured, six-month nutrition-support program. Enrolled patients would receive one of two benefit options each week: a produce box valued at roughly $30, or a produce voucher valued at roughly $20 that could be redeemed only for pre-approved healthy food items at a defined set of participating grocery stores and farmers markets.

Participation in the program was structured around a clinical framework rather than food distribution alone. Enrolled patients were scheduled to undergo three formal health assessments over the course of the program, each incorporating a nutrition evaluation, an individualized meal plan, laboratory testing, behavioral-health counseling, and oversight by a physician. The produce itself would be provided to participants at no cost, while the health center would continue to bill patients' insurance — including applicable federal health programs — for the reimbursable clinical services delivered alongside the food benefit, such as the nutrition counseling and laboratory work. The program was designed to be funded through grant dollars rather than clinical revenue, and the health center indicated an intent to eventually expand the model to patients with other nutrition-related diagnoses if the pilot proved successful.

OIG's Legal Analysis: Why the Program Implicated Federal Fraud-and-Abuse Law

Under the federal Anti-Kickback Statute, it is generally unlawful to knowingly offer, pay, solicit, or receive anything of value in exchange for referrals of, or to induce the purchase of, items or services reimbursable by a federal health-care program. OIG determined that giving patients free produce, at no cost, could reasonably be viewed as something of value capable of inducing those patients to continue receiving billable clinical services — such as the nutrition assessments, laboratory testing, and behavioral-health counseling built into the program — from that specific health center rather than from a competing provider. OIG further noted that none of the existing regulatory safe harbors, which shield certain defined categories of arrangements from AKS liability, applied to protect this particular program as designed.

OIG reached a similar conclusion under the Beneficiary Inducements CMPL, a related but distinct authority that generally prohibits offering remuneration to a Medicare or Medicaid beneficiary that the offering party knows, or should know, is likely to influence that beneficiary's selection of a particular provider for reimbursable items or services. Because the free produce was bundled together with reimbursable clinical services rather than offered as a freestanding benefit, OIG found that a commonly used CMPL exception for arrangements based on demonstrated financial need did not apply here — that exception is generally unavailable when a benefit is conditioned on, or tied to, the receipt of other reimbursable items or services.

Taken together, OIG's analysis is notable less for what it prohibits than for what it clarifies: food-as-medicine programs bundled with billable clinical services are not automatically exempt from fraud-and-abuse scrutiny simply because they serve a legitimate public-health purpose. Organizations designing similar programs must still work through the same statutory framework that governs any other arrangement involving free items tied to reimbursable care.

Why OIG Found the Risk of Fraud and Abuse Sufficiently Low

Although the arrangement technically implicated both federal authorities, OIG concluded that several specific program features reduced the practical risk of fraud and abuse enough to warrant declining enforcement action. OIG's opinion pointed to four main factors.

1. A Clear, Legitimate Clinical Purpose

OIG credited the health center's representation that the program was designed to improve management of diabetes and hypertension, promote healthier eating habits, and reduce downstream complications associated with these chronic conditions. OIG also observed that the reimbursable services delivered alongside the produce — nutrition evaluation, individualized meal planning, laboratory monitoring, and physician oversight — appeared medically appropriate in their own right and could plausibly improve patient outcomes while reducing long-term costs to federal health programs.

2. Limited Value and Limited Duration

The benefit itself was modest and time-bound: participants could receive, at most, one produce box or voucher per week, for a defined six-month program period, rather than an open-ended or escalating benefit. OIG viewed this cap on both dollar value and duration as reducing the likelihood that the produce benefit would meaningfully or improperly influence a patient's choice of provider.

3. Meaningful Program Safeguards

OIG placed significant weight on the controls built into the voucher component of the program. A third-party administrator was responsible for restricting voucher redemption to a defined list of healthy food items, monitoring how and where vouchers were actually redeemed, reviewing participant receipts, training participating retailers, and conducting periodic site visits — all governed by formal agreements specifying permissible uses of the vouchers. OIG concluded that this layered oversight structure reduced the risk that the benefit would be diverted to purposes outside the program's stated clinical goals.

4. Objective, Non-Discriminatory Eligibility Criteria

Finally, OIG noted that eligibility for the program was based on objective clinical criteria — a diagnosis of diabetes or hypertension — combined with a demonstrated financial-need standard, rather than on a patient's insurance type or coverage status. Because eligibility did not turn on whether a patient carried federal health-program coverage specifically, OIG found the design less likely to function as a mechanism for steering patients based on reimbursement potential.

Background: The Anti-Kickback Statute and the Beneficiary Inducements CMPL

The Anti-Kickback Statute and the Beneficiary Inducements CMPL are two of the primary federal tools used to prevent financial relationships from improperly influencing clinical decision-making or patient choice within federal health programs such as Medicare and Medicaid. The Anti-Kickback Statute is a criminal law that prohibits knowingly and willfully offering, paying, soliciting, or receiving remuneration to induce or reward referrals of federally reimbursable business, and it carries potential criminal penalties, civil monetary penalties, and program-exclusion consequences. The Beneficiary Inducements CMPL is a related civil authority focused specifically on remuneration offered directly to patients — rather than to referring providers — that is likely to influence a beneficiary's selection of a particular provider, practitioner, or supplier for covered items or services.

Both statutes include defined exceptions and safe harbors intended to permit common, low-risk business and clinical arrangements — for example, certain items of nominal value, or benefits offered on the basis of documented financial need — without requiring case-by-case federal review. Because food-as-medicine programs typically combine a free or discounted item (food) with reimbursable clinical services (nutrition counseling, laboratory testing, and similar services), they frequently fall into a gray area not neatly covered by any single existing exception, which is precisely why organizations increasingly turn to OIG's voluntary advisory-opinion process to obtain case-specific clarity before launching a program.

Background: Federally Qualified Health Centers and Their Role in Underserved Communities

Federally qualified health centers are community-based providers that receive federal grant funding to deliver comprehensive primary care, behavioral health, and related services to medically underserved populations, regardless of a patient's ability to pay. FQHCs are required to offer services on a sliding-fee scale based on income and are subject to a distinct set of federal grant, governance, and quality requirements overseen by the Health Resources and Services Administration (HRSA), in addition to the general Medicare and Medicaid rules that apply to most health-care providers.

Because FQHCs disproportionately serve patients facing food insecurity, housing instability, and other social determinants of health, many have become early adopters of food-as-medicine and related social-needs interventions, often supported by grant funding rather than direct clinical reimbursement. This positions FQHCs at the center of a broader national conversation about how nutrition support, health-related social needs screening, and traditional billable clinical services can be combined without running afoul of long-standing fraud-and-abuse law that was written decades before food-as-medicine programs became common.

Background: The Growing 'Food Is Medicine' Movement

Food-as-medicine programs — sometimes referred to as food is medicine, or FIM, initiatives — encompass a range of interventions that use food as a clinical tool to prevent, manage, or improve chronic health conditions. Common models include medically tailored meals for patients with complex conditions, medically tailored groceries or produce prescriptions for patients with diet-sensitive chronic diseases such as diabetes and hypertension, and produce voucher or prescription programs redeemable at grocery stores or farmers markets, similar in structure to the program addressed in Advisory Opinion 26-16.

Interest in these models has grown substantially across health systems, health plans, community health centers, and federal and state policymakers in recent years, driven by a growing evidence base linking diet-related interventions to improved outcomes for chronic conditions and by broader policy interest in addressing health-related social needs as part of comprehensive care. Several state Medicaid programs have begun piloting or formally covering food-as-medicine services through Medicaid demonstration authority, and federal agencies — including HHS's Office of Disease Prevention and Health Promotion — have published resource materials profiling food-is-medicine programs operating in community health-center settings around the country.

Against that backdrop, Advisory Opinion 26-16 is significant because it is one of the more detailed, recent examples of how a federal fraud-and-abuse regulator evaluates a food-as-medicine program that bundles a free food benefit with reimbursable clinical services — a structure that is increasingly common as more health centers and health systems attempt to formalize nutrition-support programs beyond one-off charitable food distribution.

Implications by Stakeholder Type

For Federally Qualified Health Centers

FQHCs considering similar nutrition-support programs now have a detailed, publicly available example of how OIG evaluates this type of arrangement. Advisory Opinion 26-16 offers a useful design reference: cap the benefit's dollar value and duration, tie eligibility to clinical diagnosis and documented financial need rather than coverage type, and build in independent oversight of how any voucher or in-kind benefit is redeemed. Health centers are encouraged to document the clinical rationale for a proposed program in writing before launch, and to consider whether their own arrangement is similar enough to the facts in AO 26-16 to draw meaningful comfort from it, or different enough that independent legal review or their own advisory-opinion request would be prudent.

For Hospitals and Health Systems

Hospitals and larger health systems increasingly operate food-as-medicine programs as part of community-benefit spending, population-health initiatives, or value-based care arrangements. Because many of these programs also bundle a food benefit with billable clinical services — such as dietitian visits, care-management encounters, or laboratory monitoring — the same Anti-Kickback Statute and Beneficiary Inducements CMPL analysis applies. Systems operating across multiple states or provider types should be attentive to the fact that Advisory Opinion 26-16 is fact-specific to a single FQHC's program and cannot be relied upon to protect a differently structured hospital-based initiative.

For Health Plans and Managed-Care Organizations

Medicare Advantage plans, Medicaid managed-care organizations, and other payors have also shown growing interest in covering or subsidizing food-as-medicine benefits, sometimes through supplemental benefit authority or value-added services. While health plans operate under a partially different regulatory framework than providers, the underlying concern — that a free or discounted item could improperly influence a beneficiary's health-care choices — remains relevant, and plans designing similar benefits should evaluate them against both plan-specific rules and the general fraud-and-abuse principles OIG applied in this opinion.

For Grant Funders and Philanthropic Partners

Because the program examined in AO 26-16 was funded through grant dollars rather than clinical revenue, funders supporting similar initiatives may want to understand how their grantees are structuring eligibility, benefit value, and oversight, since a well-designed compliance framework can be a meaningful factor in a program's long-term sustainability and its ability to expand or be replicated across additional health centers.

A Practical Design Checklist Drawn from Advisory Opinion 26-16

While every organization's facts differ, and this release is not a substitute for individualized legal advice, the factors OIG highlighted in AO 26-16 suggest several practical questions program designers may want to work through early in the planning process:

● Clinical rationale: Is there a documented, condition-specific clinical justification for the nutrition benefit, tied to recognized diagnoses such as diabetes or hypertension?

● Benefit value and duration: Is the benefit capped at a modest dollar value per period, and limited to a defined program length rather than open-ended?

● Use restrictions: If a voucher or card-based benefit is used, is redemption restricted to a defined list of healthy food items rather than general merchandise?

● Independent oversight: Is a third party responsible for monitoring redemption, reviewing receipts, training participating retailers, and conducting periodic site visits?

● Eligibility criteria: Is eligibility based on clinical diagnosis and documented financial need, rather than a patient's insurance type or coverage status?

● Documentation: Are the clinical services delivered alongside the food benefit — assessments, counseling, laboratory work — independently medically appropriate and properly documented?

● Funding source: Is the program supported by grant or philanthropic funding rather than structured to maximize billable service volume?

● Legal review: Has the arrangement been reviewed by fraud-and-abuse counsel, and has the organization considered whether to seek its own OIG advisory opinion before launch?

Historical Context: OIG Scrutiny of Patient Inducements

OIG has evaluated the boundaries of permissible patient inducements for decades, issuing advisory opinions and regulatory guidance addressing a wide range of arrangements — from free transportation to appointments, to cost-sharing waivers, to local transportation and meal programs offered by hospitals and health systems. Over time, OIG has generally shown more flexibility toward items of modest value that are closely tied to a legitimate clinical purpose and that include safeguards against overuse or diversion, while remaining more skeptical of higher-value, open-ended, or poorly documented benefits.

Nutrition-focused benefits sit within this same general framework but had, until relatively recently, been examined less frequently by OIG than categories such as transportation or cost-sharing waivers. Advisory Opinion 26-16 is therefore a useful and relatively rare data point specifically addressing produce-based benefits, adding to a smaller but growing body of OIG guidance on food-as-medicine arrangements as these programs have become more common across the health-care system.

Significance for the Broader Health-Care Field

Although Advisory Opinion 26-16 legally binds only the requesting health center, and only with respect to the exact facts it presented, the opinion is being closely read across the field as a signal of how OIG currently approaches food-as-medicine and other social-determinants-of-health programs more broadly. The opinion suggests that OIG is willing to evaluate these arrangements on their individual clinical merits and safeguards, rather than treating the mere presence of a free item bundled with billable services as automatically disqualifying.

At the same time, the opinion is a clear reminder that food-as-medicine programs are not exempt from fraud-and-abuse law by virtue of their public-health purpose. OIG expressly found that the arrangement implicated both the Anti-Kickback Statute and the Beneficiary Inducements CMPL before exercising discretion not to pursue sanctions — it did not conclude that food-as-medicine programs fall outside these statutes altogether. Organizations designing similar initiatives are expected to build in comparable safeguards: a documented clinical rationale, benefits that are limited in value and duration, defined controls over how any voucher or in-kind benefit can be used, and eligibility criteria grounded in clinical and financial need rather than a patient's insurance status.

Health systems, hospitals, accountable care organizations, health plans, and community-based organizations exploring similar nutrition-support models are increasingly expected to treat OIG's advisory-opinion process, along with careful internal fraud-and-abuse review, as a standard part of program design — not an afterthought layered on once a pilot is already underway.

Why This Matters for Patients

For patients managing diet-sensitive chronic conditions such as diabetes and hypertension, consistent access to fresh produce can be a meaningful barrier to better health outcomes, particularly for patients who are also navigating food insecurity. Advisory Opinion 26-16 does not create any new patient benefit on its own — it applies only to the single FQHC that requested it — but it illustrates a model that patients may increasingly encounter as more health centers and health systems formalize nutrition-support programming. Patients enrolled in similar programs elsewhere should expect that any free food benefit tied to their care will typically come with structured clinical touchpoints, such as nutrition counseling or periodic health assessments, rather than being offered as a standalone giveaway.

Patient advocates have generally welcomed the broader trend toward food-as-medicine programming, while also emphasizing that programs should be transparent with patients about how their participation, health data, and any related billing will be handled. Because the health center in AO 26-16 continued to bill applicable insurance for the clinical services delivered alongside the free produce, patients enrolled in comparable programs should expect that standard billing practices, co-payments, or cost-sharing may still apply to the reimbursable services portion of a program, even when the food itself is provided at no cost.

What Comes Next

OIG advisory opinions do not typically trigger immediate nationwide policy changes, since each opinion is legally limited to the requesting organization. However, opinions like AO 26-16 often influence how other organizations, their legal counsel, and industry associations approach similar program design going forward, and they are frequently cited in subsequent compliance guidance, conference presentations, and internal policy memos across the health-care field. Additional OIG advisory opinions addressing food-as-medicine or other social-determinants-of-health arrangements may follow as more organizations submit their own requests seeking similar clarity.

Separately, state Medicaid agencies continue to explore whether and how to formally cover food-as-medicine services through Medicaid demonstration waivers, which operate under a different legal framework than the fraud-and-abuse analysis in AO 26-16 but reflect the same broader policy trend toward integrating nutrition support into mainstream health-care financing. HealthBridge US will continue to monitor both tracks — OIG fraud-and-abuse guidance and state Medicaid coverage policy — as they evolve.

The Evidence Base Behind Food-as-Medicine Interventions

Interest in food-as-medicine programming has been reinforced by a growing body of research examining how nutrition-focused interventions affect chronic-disease management and health-care utilization. Studies of medically tailored meal and produce-prescription programs delivered through community health centers and food-bank partnerships have reported associations with improvements in blood-sugar control, blood pressure, body-mass index, and self-reported dietary quality among participants with diabetes, hypertension, and related conditions. Some evaluations have also reported reductions in hospitalizations or emergency-department use among enrolled patients, which is part of why federal and state policymakers have framed these programs as having the potential to improve outcomes while moderating long-term costs to public health programs.

It is this evidence base — combined with the practical safeguards built into the specific program at issue — that OIG pointed to when it credited the requesting FQHC's stated clinical rationale in Advisory Opinion 26-16. Organizations designing similar programs are increasingly expected to ground their clinical justification not only in general public-health interest, but in specific, documented evidence connecting the proposed intervention to the target population's diagnoses and expected outcomes.

Related Federal Program-Integrity Priorities

Advisory Opinion 26-16 arrives amid continued federal attention to program integrity across Medicare and Medicaid more broadly, including ongoing OIG and CMS work addressing improper billing, beneficiary inducement, and fraud risk across a range of emerging care models. Organizations operating food-as-medicine or other social-needs programs should view fraud-and-abuse compliance as one component of a broader program-integrity posture that also includes accurate billing documentation, routine internal auditing, and staff training on applicable federal and state requirements — the same fundamentals that apply across other categories of federally funded health-care services.

Statement from HealthBridge US

HealthBridge US views Advisory Opinion 26-16 as a constructive, if cautionary, data point for any organization pursuing food-as-medicine or other health-related social-needs programming. The opinion confirms that thoughtfully designed nutrition interventions can coexist with federal fraud-and-abuse law, but only when program design treats compliance as a foundational element rather than a secondary consideration.

“This opinion is a green light with conditions attached, not a blanket exemption. Programs that can clearly show a legitimate clinical purpose, keep the benefit modest and time-limited, build in real oversight of how vouchers or in-kind benefits are used, and base eligibility on clinical and financial need rather than coverage type are the ones most likely to hold up to this same level of scrutiny.”
— [Spokesperson Name], [Title], HealthBridge US

HealthBridge US notes that the health-care field will likely see continued growth in food-as-medicine programming across FQHCs, hospitals, and health plans, particularly as more state Medicaid programs formally cover nutrition-support services through demonstration waivers. HealthBridge US intends to continue tracking OIG guidance, state Medicaid coverage policy, and emerging best practices in this space, and will share additional plain-language updates as new federal or state developments are announced.

“Every organization we've talked with about nutrition-support programming wants to do right by their patients. The lesson from this opinion is that doing right by patients and staying inside federal fraud-and-abuse law are not competing goals — they both come down to the same disciplined program design.”
— [Spokesperson Name], [Title], HealthBridge US

Key Takeaways at a Glance

● HHS OIG issued Advisory Opinion 26-16, declining to impose sanctions on an FQHC's proposed food-as-medicine program despite finding it implicated both the Anti-Kickback Statute and the Beneficiary Inducements CMPL.

● The program offered free weekly produce boxes or produce vouchers, worth roughly $20 to $30, to 50 financially needy patients with diabetes or hypertension over a six-month period.

● Participants also received reimbursable clinical services — nutrition assessments, individualized meal planning, laboratory testing, and behavioral-health counseling — billed to insurance and applicable federal health programs.

● OIG's favorable opinion rested on a legitimate clinical purpose, limited benefit value and duration, strong third-party oversight of voucher use, and eligibility criteria based on clinical and financial need rather than insurance status.

● The opinion is binding only on the requesting health center and does not exempt food-as-medicine programs from fraud-and-abuse law generally.

● Organizations considering similar programs are encouraged to build in comparable safeguards and to consult fraud-and-abuse counsel or seek their own OIG advisory opinion before launching.

● The opinion adds to a growing, closely watched body of federal guidance on how nutrition-focused social determinants of health programs intersect with longstanding fraud-and-abuse law.

Frequently Asked Questions About OIG Advisory Opinion 26-16

What is an OIG advisory opinion?

An OIG advisory opinion is a formal, legally binding response from the HHS Office of Inspector General to a specific organization's request for guidance on whether a proposed arrangement would violate federal fraud-and-abuse laws such as the Anti-Kickback Statute or the Civil Monetary Penalties Law. It applies only to the requesting party and only to the exact facts presented.

Does this opinion mean all food-as-medicine programs are now permitted?

No. OIG found that the specific arrangement implicated both the Anti-Kickback Statute and the Beneficiary Inducements CMPL, and only declined to pursue sanctions because of the program's particular safeguards, limited scope, and clinical justification. Other organizations cannot legally rely on this opinion to protect their own, differently designed programs.

Why did the free produce implicate federal fraud-and-abuse law at all?

Because the health center also billed for reimbursable clinical services delivered alongside the free produce, OIG determined the produce could be viewed as remuneration capable of influencing which provider a patient selects for those billable services — the core concern both the Anti-Kickback Statute and the Beneficiary Inducements CMPL are designed to address.

What safeguards did OIG find persuasive?

OIG pointed to the program's clear clinical purpose, the modest dollar value and six-month time limit on the benefit, third-party oversight restricting voucher redemption to approved healthy foods, and eligibility criteria based on diagnosis and financial need rather than insurance coverage type.

Who oversees federally qualified health centers generally?

FQHCs receive federal grant funding and are overseen by the Health Resources and Services Administration (HRSA), in addition to being subject to the Medicare, Medicaid, and general fraud-and-abuse rules that apply to health-care providers more broadly.

Can other health centers or health systems copy this exact program?

They can use it as a helpful design reference, but because advisory opinions are fact-specific and legally binding only on the requestor, any organization considering a similar program should have its own arrangement independently reviewed by fraud-and-abuse counsel, and may choose to seek its own advisory opinion from OIG.

Where can I read the full advisory opinion?

The complete text of Advisory Opinion 26-16 is published by the HHS Office of Inspector General. A direct government link is provided in the references section of this release.

Does this opinion apply to Medicare Advantage supplemental benefits?

No. Advisory Opinion 26-16 addresses a specific FQHC arrangement analyzed under the Anti-Kickback Statute and Beneficiary Inducements CMPL. Medicare Advantage supplemental benefits, including any food or nutrition-related benefits, are governed by a separate regulatory framework administered by CMS.

What happens if an organization launches a similar program without seeking its own advisory opinion?

Seeking an advisory opinion is voluntary, not required. An organization may proceed without one, but it would not have the same degree of regulatory certainty and would bear the risk that OIG or another enforcement agency later views its specific program differently than it viewed the arrangement in AO 26-16.

Did OIG say food-as-medicine programs are generally low risk?

OIG's conclusion was specific to the facts presented in this opinion. OIG did not issue a general statement that food-as-medicine programs are categorically low risk; it evaluated this particular program's safeguards and found the risk sufficiently low in this instance to decline enforcement action.

Key Terms Referenced in This Release

This release discusses the following topics and terms, provided here for clarity and reference: OIG Advisory Opinion 26-16, food-as-medicine program compliance, FQHC produce benefit, Anti-Kickback Statute food is medicine, Beneficiary Inducements CMPL, federal fraud and abuse enforcement discretion, social determinants of health programs, produce prescription and voucher programs, federally qualified health center nutrition benefits, HHS OIG advisory opinion process, produce prescription programs Medicaid, nutrition security chronic disease management, and HealthBridge US health-care compliance advocacy.

About HealthBridge US

HealthBridge US is a healthcare organization focused on helping providers, health centers, and health plans design accountable, evidence-based programs that improve patient outcomes while operating within federal and state health-care compliance requirements. HealthBridge US tracks federal regulatory guidance — including OIG advisory opinions, CMS program policy, and related developments — to help the organizations it works with pursue innovative care models, including nutrition and social-determinants-of-health programming, with confidence. [This boilerplate paragraph can be customized with additional company-specific detail, mission language, service lines, geographic footprint, and founding information.]

Media Contact

[Contact Name]

[Title], HealthBridge US

[Phone Number]

[Email Address]

[Company Website URL]

Editorial Note

This release is an independent summary and commentary prepared by HealthBridge US regarding a federal regulatory development. It is intended for general informational purposes and does not constitute legal, clinical, billing, or compliance advice. OIG Advisory Opinion 26-16 is binding only on the requesting organization and applies only to the specific facts it presented; it should not be relied upon as authorization for any other organization's program. Organizations considering a similar initiative should consult qualified fraud-and-abuse counsel or seek their own advisory opinion from OIG.

Government Source References

The following official U.S. government sources were referenced in the preparation of this release:

● HHS Office of Inspector General — Advisory Opinion 26-16 (full text): https://oig.hhs.gov/documents/advisory-opinions/11795/AO-26-16.pdf

● OIG.HHS.gov — Advisory Opinions: https://oig.hhs.gov/compliance/advisory-opinions/

● OIG.HHS.gov — Anti-Kickback Statute and Safe Harbor Regulations: https://oig.hhs.gov/compliance/safe-harbor-regulations/

● HRSA.gov — Health Center Program (Federally Qualified Health Centers): https://www.hrsa.gov/opa/eligibility-and-registration/health-centers

● HHS.gov — Office of Disease Prevention and Health Promotion, Food Is Medicine: https://odphp.health.gov/foodismedicine

● HHS.gov — U.S. Department of Health and Human Services Newsroom: https://www.hhs.gov/about/news/index.html

● Medicaid.gov — Program Integrity: https://www.medicaid.gov/medicaid/program-integrity/index.html